Navigation Links
Fuel cells utilised to produce electricity from process industry by-product hydrogen
Date:6/17/2014

VTT Technical Research Centre of Finland has developed a pilot-scale power plant based on fuel cells that utilises by-product hydrogen from the process industry. The power plant has been in operation at Kemira Chemicals Oy's site in Finland since January 2014. The system produces electricity from hydrogen generated as a by-product of a sodium chlorate process at a high electric efficiency and is the first of its kind in the Nordic Countries.

When scaled into commercial size, the equipment enables the reduction of energy consumption of the electrolysis process used for sodium chlorate production by 10%. The Kemira site's annual electricity consumption is approximately 578 GWh.

A few similar plants have been built elsewhere in the world, for example in the Netherlands and North America. The electric power of the pilot plant is approximately 50 kW. The total electrical efficiency of the system, including the fuel utilisation ratio and the power losses due to auxiliary equipment and power electronics, is approximately 44%, while the fuel cell itself is operating at an electrical efficiency of 54%. The power plant is based on PEM fuel cells - the same technology that is considered most promising for the fuel cell vehicles.

At the moment, the low-temperature fuel cell at the Kemira Chemicals site operates at approximately 60 C. In the future, utilization of the waste heat produced by the system is expected to also improve. This is achieved through development of fuel cell materials, which enable higher operating temperatures. One goal of the DuraDemo project, coordinated by VTT, has been to gather user experience of operating a fuel cell system in an actual end-user application in an industrial environment. The system performance has been recorded and analysed to confirm the assumed level of readiness of PEMFC from technological and commercial point of view and dealing with potential unresolved problems related to this in the by-product hydrogen
'/>"/>

Contact: Timo Keränen
timo.keranen@vtt.fi
358-405-658-390
VTT Technical Research Centre of Finland
Source:Eurekalert

Page: 1 2

Related biology news :

1. Stem cells in neurodegeneration: challenges and future neurotherapeutic prospects
2. Proliferation cues natural killer cells for job change
3. Guidelines needed for creating germ cells in vitro, Cornell, JAX scientists state
4. Coral, human cells linked in death
5. New class of nanoparticle brings cheaper, lighter solar cells outdoors
6. Specific protein may help beta cells survive in type 1 diabetes
7. Tangled path of Alzheimers-linked brain cells mapped in mice
8. Scientists reveal details of calcium safety-valve in cells
9. Stem cells hold keys to bodys plan
10. Stem cells found to play restorative role when affecting brain signaling process
11. First demonstration in human cells of chromosomal translocations that cause certain cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2014)... the greatest challenges in modern medicine is developing drugs ... minimal toxicity and side-effects to the patient. Such properties ... drug molecule. Ideally, the drug should have a shape ... that it binds it with high specificity. Publishing in ... synthetic amino acid that can impact the 3D structure ...
(Date:8/31/2014)... malaria diagnosis has changed very little. After taking a blood ... a glass slide, stains it with a special dye, and ... the disease. This approach gives an accurate count of how ... of disease severity but is not ideal because there ... the Singapore-MIT Alliance for Research and Technology (SMART) has now ...
(Date:8/29/2014)... recently, little has been known about what genetic changes ... of scientists, one of whom is a University of ... that genes controlling the development of the brain and ... The study was published Aug. 28 in Science ... is online at http://www.sciencemag.org/ ., The domestication of ...
Breaking Biology News(10 mins):A new synthetic amino acid for an emerging class of drugs 2A new synthetic amino acid for an emerging class of drugs 3A new way to diagnose malaria 2A new way to diagnose malaria 3New research reveals how wild rabbits were genetically transformed into tame rabbits 2New research reveals how wild rabbits were genetically transformed into tame rabbits 3
... CAMBRIDGE, Mass. (March 16, 2011) Renowned cancer researchers ... Douglas Hanahan, Director of the Swiss Institute for Experimental ... "Hallmarks of Cancer," which has influenced the study of ... a decade. Published in January 2000, their original ...
... Global Change Biology Bioenergy proposes a new method ... in bioenergy systems. CO 2 emissions resulting from ... and environmental impact studies because bioenergy is carbon- and climate- ... combustion are sequestered by growing biomass. Its climate impact has ...
... Mass., March 16, 2011 The nutritional content of ... as owner,s perceptions about them, according to a study ... School of Veterinary Medicine at Tufts University. ... humans and petschange with aging, the Association of American ...
Cached Biology News:Whitehead scientist helps revisit 'Hallmarks of Cancer' 2Whitehead scientist helps revisit 'Hallmarks of Cancer' 3Wide variety in nutritional content found in 'senior' dog foods 2Wide variety in nutritional content found in 'senior' dog foods 3
(Date:8/29/2014)... (PRWEB) August 29, 2014 Intrinsic ... 13485:2003 certified, GAMP® 5 compliant imaging core lab, ... international Phase II clinical trial to assess a ... Throughout this trial, Intrinsic Imaging will provide comprehensive ... to, protocol and charter development, site qualification, site ...
(Date:8/28/2014)... 2014 “This kit has an improved extraction ... 0 to 150 ppb,” said Mark Tess, PhD, Mycotoxin Product ... to plant owners and USDA-GIPSA inspection agencies that have a ... can take place in a matter of minutes with nothing ... test the feed and grain before accepting it, but they ...
(Date:8/28/2014)... The ability for organizations to attract top ... individuals to perform at the highest of levels, are ... to compete in this post–recession era. The pharmaceutical ... the sector increasingly focuses on the importance of employee-fit ... real results on the organization's development and the innovation ...
(Date:8/28/2014)... Aug. 28, 2014  Armetheon, Inc. ( www.armetheon.com ... mid- to late-stage cardiovascular drug candidates, today announced ... first round of financing. The Series A round ... Bioventures with participation from investors that included Atheneos ... Dr. Larry Hsu , the founder of ...
Breaking Biology Technology:Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 3Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 3
... Below is,updated text of Shire plc,s conference call notification. ... been updated from an earlier,release. Shire PLC (LSE: ... will announce third quarter 2007 earnings on,Thursday 1 November ... 12:00 GMT / 08:00 ET, Investor meeting and ...
... (Nasdaq: ARNA ) today reported financial results for ... in the third quarter of 2007 were $5.0 million, ... Total revenues in the first,nine months of 2007 were ... months of 2006. Revenues in the first nine months ...
... Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) today announced that ... on Wednesday, October 24,2007 after the market closes. The ... 5:00 p.m. ET, which will be open to the ... company will review,the financial results and discuss other business ...
Cached Biology Technology:Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007 2Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 2Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 3Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 4Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 5Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 6Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results 7Sangamo BioSciences Announces Third Quarter 2007 Conference Call and Webcast 2
... COOLSCOPE is an integrated digital microscope and ... computer, equipment setup, optical adjustment or software ... innovative technology, COOLSCOPE combines simplicity and advanced ... COOLSCOPE offers simultaneous viewing of a macro ...
... kit provides complete components including positive ... detection of DNA fragmentation in cultured ... of BrdU in the procedure provides ... methods. Results can be analyzed by ...
... Life Science LAS-3000 imaging system combines ... simplified user interface, providing significantly improved ... of modularities. The system is especially ... perfect standard system for Western blotting ...
... Science LAS-3000mini is a compact image ... applications, and the perfect standard system ... LAS-3000 provides significantly improved system sensitivity ... calibration standards validate that Fujis LAS-3000 ...
Biology Products: